SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-09-033315
Filing Date
2009-08-11
Accepted
2009-08-11 09:30:46
Documents
7
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 CORNERSTONE THERAPEUTICS INC. b76228e10vq.htm 10-Q 357647
2 EX-10.16 SEVERANCE AGREEMENT AND GENERAL RELEASE b76228exv10w16.htm EX-10.16 37598
3 EX-10.25 SEPARATION LETTER AGREEMENT AND GENERAL RELEASE b76228exv10w25.htm EX-10.25 50824
4 EX-31.1 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER b76228exv31w1.htm EX-31.1 8198
5 EX-31.2 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER b76228exv31w2.htm EX-31.2 8211
6 EX-32.1 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER b76228exv32w1.htm EX-32.1 4276
7 EX-32.2 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER b76228exv32w2.htm EX-32.2 4303
  Complete submission text file 0000950123-09-033315.txt   472599
Mailing Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518
Business Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518 919-678-6611
CORNERSTONE THERAPEUTICS INC (Filer) CIK: 0001145404 (see all company filings)

IRS No.: 043523569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50767 | Film No.: 091002232
SIC: 2834 Pharmaceutical Preparations